Published on 09/12/2025

Change Management for Reports & Dashboards

Change management is a critical function in ensuring that the validity and reliability of reports and dashboards within the biopharmaceutical industry are maintained throughout their life cycles. As the sector increasingly adopts cloud-based solutions and software as a service (SaaS) models for data governance, it is vital for organizations to understand change management principles in the context of compliance with relevant regulations such as the US FDA, EMA, MHRA, and PIC/S guidelines. This tutorial provides a detailed guide on implementing effective change management strategies for reports and dashboards, focusing on critical areas including intended use, configuration/change control, auditing processes, disaster recovery testing, data retention, and archive integrity.

1. Understanding Change Management in a Regulatory Context

Effective change management starts with a comprehensive understanding of its role in compliance with regulations governing biopharmaceutical products, particularly those relating to Computer Software Assurance (CSA) and Computer System Validation (CSV). Regulatory bodies, including the FDA and EMA, have outlined expectations for organizations to ensure that their methods for managing changes to systems are robust and documented.

Change management in this context includes managing changes to software applications used for data collection, analysis, and reporting. Such changes may also extend to cloud environments where reports and dashboards are hosted. Therefore, organizations must establish a clear and regulated process to evaluate, document, and monitor changes to ensure ongoing compliance.

The following steps are essential in understanding this regulatory framework:

• Regulatory Guidance: Refer to the FDA’s Guidance for Industry regarding electronic records and signatures which highlight compliance expectations, including Part 11 and Annex 11 requirements.
• Governance Frameworks: Incorporate guidelines from PIC/S and ICH, which provide a structured approach to implementing change control that aligns with Good Manufacturing Practices (GMP).
• Risk Assessment: Conduct a risk assessment for software and processes that identifies potential impacts of changes to data integrity and regulatory compliance.

2. Identifying Intended Use and Risk Assessment

The first step in change management involves clearly identifying the intended use of reports and dashboards. This includes determining the critical data elements, how they will be used, and the regulatory requirements that govern them. Biopharmaceutical companies must ensure that these systems comply with both industry standards and regulatory expectations through a thorough risk assessment process.

Key considerations in this process include:

• Define System Purpose: Document the exact purpose of reports and dashboards, including who will be utilizing them and their intended outcomes. This ensures that all stakeholders align on the requirements.
• Identify Regulatory Requirements: Map out the relevant regulations that impact your reporting systems, including FDA, EMA, and other regional guidelines.
• Assess Data Risks: Evaluate the inherent risks associated with changes to the reports or dashboards, focusing on potential risks to data integrity, including data loss or incorrect reporting.

3. Implementing Configuration/Change Control Procedures

Effective configuration and change management controls are essential to mitigate the risks identified in earlier stages. Organizations must define and implement a configuration management process that includes the following elements:

• Change Request Process: Create a structured process for submitting, reviewing, and approving change requests that identify each change’s potential impact.
• Version Control: Maintain detailed version histories of the reports and dashboards, documenting what changes were made, when, and who authorized them.
• Validation of Changes: Changes that affect the functionality of reports or dashboards must undergo a validation process to ensure compliance with predefined criteria. This may include retesting utilizing baseline requirements from the initial validation effort.

Moreover, implementing an effective audit trail is paramount to enable traceability of changes. This includes ensuring that all change-related activities and decisions are documented consistently within an audit trail library.

4. Backups and Disaster Recovery Testing

In the event of a system failure, an effective backup and disaster recovery (DR) plan is crucial in maintaining data integrity. Organizations must implement robust protocols as part of their change management strategy to ensure data preservation and minimize the impact of disruptions. Key components of establishing a backup and DR strategy include:

• Backup Procedures: Define procedures for regular backups, specifying the frequency and scope of data that should be backed up. Ensure that backups include all necessary components for both the reports and the underlying databases.
• Disaster Recovery Testing: Regularly test the disaster recovery plan to ensure all components worked and that employees understand their roles. Documentation of DR test results—including any failures or lessons learned—is essential for ongoing improvement.
• System Redundancy: Integrate redundancy into your systems to ensure continuity of operations across all reporting and dashboard functionalities.

5. Conducting Comprehensive Audit Trail Reviews

Audit trails are an essential component of compliance in report validation. These tracks of who changed what, when, and why, contribute significantly to an organization’s ability to ensure data integrity and regulatory compliance. Organizations should develop processes for reviewing audit trails that include:

• Review Policies: Establish and document policies detailing how often audit trails will be reviewed, which should occur regularly and be conducted by trained personnel.
• Criteria for Review: Define the criteria for what constitutes an acceptable change and what parameters will necessitate further investigation.
• Documentation: Ensure that all findings from audit trail reviews are documented and that any necessary follow-up actions are taken and recorded.

6. Implementing Report and Spreadsheet Validation Controls

Validation of reports and spreadsheets is a critical aspect of maintaining compliance within biopharmaceutical organizations. To ensure the accuracy and reliability of data presented through reports and dashboards, organizations should follow structured validation controls:

• Validation Planning: Prepare validation plans that define the scope, methodologies, and acceptance criteria for the report and spreadsheet validation activities.
• Testing Strategies: Apply appropriate testing strategies, such as peer reviews and pre-determined acceptance criteria for output outputs against expected results.
• Documentation: All validation activities must be thoroughly documented, including results, methodologies, and any deviations encountered during the testing process.

7. Ensuring Data Retention and Archive Integrity

A well-defined data retention strategy that aligns with legal obligations and corporate policies is necessary for maintaining data compliance. Importance should be placed on both the accessibility and integrity of data throughout its lifecycle:

• Retention Policies: Establish policies that dictate how long various kinds of reports and data must be retained, taking into account regulatory requirements in the regions where you operate, including the US and EU.
• Archival Procedures: Implement efficient archiving procedures that facilitate easy access while preventing unauthorized alterations or deletions of historical data.
• Audit Review of Archived Data: Conduct periodic audits of archived data to ensure that data integrity is maintained and that retention policies are continually adhered to.

8. Continuous Improvement and Training

The landscape of biopharmaceutical regulations is continuously evolving, and organizations must adapt their change management strategies accordingly. Continuous improvement is essential, and organizations should implement training and Ongoing professional development activities for employees who handle reports and dashboards:

• Training Programs: Develop targeted training programs that focus on the latest regulatory guidelines and internal procedures pertaining to report and dashboard management.
• Feedback Mechanisms: Encourage employees to share perspectives on the change management processes to identify improvement opportunities.
• Review and Update Policies: Regularly review and update change management policies to reflect current practices and regulatory changes, ensuring they continue to meet industry standards.

By following a structured and compliant change management process specifically tailored for reports and dashboards, biopharmaceutical organizations can ensure the integrity and reliability of their data reporting mechanisms while meeting regulatory expectations.